Frequent expression of CD30 antigen in the primary gastric non-B, non-Hodgkin lymphomas

Pathology International

Volumn 54, Issue 7, 2004, Pages 503-509

  Iwamizu Watanabe, Sachiko ^a   Yamashita, Yoriko ^a   Yatabe, Yasushi ^b   Nakamura, Shigeo ^b   Mori, Naoyoshi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

ALCL; CD30 antigen; Gastric lymphoma; Non B; Non Hodgkin lymphoma; Stomach

Indexed keywords

ANTINEOPLASTIC AGENT; CD30 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; PHOSPHOTRANSFERASE;

ADULT; AGED; ANAPLASTIC CARCINOMA; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHROMOSOME REARRANGEMENT; CLINICAL FEATURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MALE; MIXED CELL LYMPHOMA; MORPHOLOGY; NONHODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; STOMACH LYMPHOMA; SURVIVAL RATE; T LYMPHOCYTE; TUMOR CELL;

ADULT; AGED; ANTIGENS, CD30; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, LARGE-CELL, KI-1; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 3242724814     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2004.01657.x     Document Type: Article

References (44)

1. Nakamura S, Akazawa K, Yao T, Tsuneyoshi M. Primary gastric lymphoma: a clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index. Cancer 1995; 76: 1313-24.
2. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol 1994; 25: 1020-29.
3. Isaacson PG, Müller-Hermelink HK, Paris MA et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001; 157-60.
4. Mori N, Yatabe Y, Oka K et al. Primary gastric Ki-1 positive anaplastic large cell lymphoma: a report of two cases. Pathol Int 1994; 44: 164-9.
5. Murata T, Nakamura S, Oka K et al. Granzyme B-positive primary gastric T-cell lymphoma: gastric T-cell lymphoma with the possibility of extrathymic T cell origin. Pathol Int 2000; 50: 853-7.
6. Watanabe M, Moriyama Y. Primary gastric T-cell lymphoma without human T-lymphotropic virus type 1: report of a case. Surg Today 2002; 32: 525-30.
7. Yatabe Y, Mori N, Oka K, Nakazawa M, Asai J. Primary gastric T-cell lymphoma. Morphological and immunohistochemical studies of two cases. Arch Pathol Lab Med 1994; 118: 547-50.
8. Tokunaga O, Watanabe T, Shimamoto Y, Tokudome S. Primary T-cell lymphoma of the gastrointestinal tract associated with human T-cell lymphotropic virus type I. An analysis using in situ hybridization and polymerase chain reaction. Cancer 1993; 71: 708-16.
9. Shimada-Hiratsuka M, Fukayama M, Hayashi Y et al. Primary gastric T-cell lymphoma with and without human T-lymphotropic virus type 1. Cancer 1997; 80: 292-303.
10. Horie R, Yatomi Y, Wakabayashi T et al. Primary gastric T-cell lymphomas: report of two cases and a review of the literature. Jpn J Clin Oncol 1999; 29: 171-8.
11. Hatano B, Ohshima K, Katoh A et al. Non-HTLV-1-associated primary gastric T-cell lymphomas show cytotoxic activity: clinicopathological, immunohistochemical characteristics and TIA-1 expression in 31 cases. Histopathology 2002; 41: 421-36.
12. Lee SS, Jang JJ, Cho KJ, Khang SK, Kim CW. Epstein-Barr virus-associated primary gastrointestinal lymphoma in non-immunocompromised patients in Korea. Histopathology 1997; 30: 234-42.
13. Nakamura S, Yao T, Aoyagi K, Iida M, Fujishima M, Tsuneyoshi M. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer 1997; 79: 3-11.
14. Itatsu T, Miwa H, Ohkura R et al. Primary gastric T-cell lymphoma accompanied by HTLV-1, HBV and H. pylori infection. Dig Dis Sci 1999; 44: 1823-36.
15. Bariol C, Field A, Vickers CR, Ward R. Regression of gastric T cell lymphoma with eradication of Helicobacter pylori. Gut 2001; 48: 269-71.
16. Banerjee D, Walton JC, Jory TA, Crukley C, Meek M. Primary gastric T-cell lymphoma of suppressor-cytotoxic (CD8+) phenotype: discordant expression of T-cell receptor subunit beta F1, CD7, and CD3 antigens. Hum Pathol 1990; 21: 872-4.
17. Holst VA, Locker J, Gleason JA, Swerdlow SH. Aggressive gastric peripheral T-cell lymphoma of CD8+ type associated with lymphomatous meningitis. Mod Pathol 1997; 10: 504-9.
18. Dargent JL, Roufosse C, Vanderschueren B et al. Natural killer-like T-cell lymphoma of the stomach. Scand J Gastroenterol 1999; 34: 445-8.
19. Barth TF, Leithauser F, Dohner H et al. Primary gastric apoptosis-rich T-cell lymphoma co-expressing CD4, CD8, and cytotoxic molecules. Virchows Arch 2000; 436: 357-64.
20. Foss HD, Schmitt-Graff A, Daum S et al. Origin of primary gastric T-cell lymphomas from intraepithelial T-lymphocytes: report of two cases. Histopathology 1999; 34: 9-15.
21. Paulli M, Rosso R, Kindl S et al. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases. Cancer 1994; 73: 541-9.
22. Nakamura S, Aoyagi K, Ohkuni A, Kimura Y, Tsuneyoshi M, Fujishima M. Rapidly growing primary gastric CD30 (Ki-1)-positive anaplastic large cell lymphoma. Dig Dis Sci 1998; 43: 300-5.
23. Stein H, Gerdes J, Schwab U et al. Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer 1982; 30: 445-59.
24. Schwab U, Stein H, Gerdes J et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299: 65-7.
25. Stein H, Mason DY, Gerdes J et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848-58.
26. Gerdes J, Schwarting R, Stein H. High proliferative activity of Reed Sternberg associated antigen Ki-1 positive cells in normal lymphoid tissue. J Clin Pathol 1986; 39: 993-7.
27. Delsol G, Ralfkiaer E, Stein H et al. Anaplastic large cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardimarr JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001; 230-35.
28. Stein H, Foss HD, Durkop H et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000; 96: 3681-95.
29. Jaffe ES. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod Pathol 2001; 14: 219-28.
30. Weisenburger DD, Anderson JR, Diebold J et al. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project. Am J Hematol 2001; 67: 172-8.
31. Smith CA, Gruss HJ, Davis T et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993; 73: 1349-60.
32. Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994; 83: 2045-56.
33. Gilfillan MC, Noel PJ, Podack ER, Reiner SL, Thompson CB. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines. J Immunol 1998; 160: 2180-87.
34. Muta H, Boise LH, Fang L, Podack ER. CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis. J Immunol 2000; 165: 5105-11.
35. Ralfkiaer E, Delsol G, Willemze R et al. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001; 221-4.
36. Krenacs L, Wellmann A, Sorbara L et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997; 89: 980-89.
37. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-6.
38. Eidt S, Stolte M, Fischer R. Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas. J Clin Pathol 1994; 47: 436-9.
39. YeG, Barrera C, Fan X et al. Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection. J Clin Invest 1997; 99: 1628-36.
40. Terres AM, Pajares JM. An increased number of follicles containing activated CD69+ helper T cells and proliferating CD71+ B cells are found in H. pylori-infected gastric mucosa. Am J Gastroenterol 1998; 93: 579-83.
41. Kitajima S, Tokunaga M, Goto M et al. Monoclonal antibody HML-1 reactivity with adult T-cell leukaemia/lymphoma and other lymphomas. Histopathology 1994; 25: 229-36.
42. Katoh A, Ohshima K, Kanda M et al. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells. Leuk Lymphoma 2000; 39: 97-111.
43. Cerf-Bensussan N, Jarry A, Brousse N, Lisowska-Grospierre B, Guy-Grand D, Griscelli C. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol 1987; 17: 1279-85.
44. Spencer J, Cerf-Bensussan N, Jarry A et al. Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol 1988; 132: 1-5.